174 related articles for article (PubMed ID: 4830942)
1. [Role of resuscitation in incidents due to iodine contrast media].
Testa S
Minerva Anestesiol; 1974 Apr; 40(4):177-92. PubMed ID: 4830942
[No Abstract] [Full Text] [Related]
2. [Complications related to the administration of iodinated contrast media].
Cappeliez O; Lemort M; Dagnelie J
Rev Med Brux; 1997 Dec; 18(6):373-8. PubMed ID: 9481156
[TBL] [Abstract][Full Text] [Related]
3. Nursing guidelines and discharge planning for patients receiving recombinant interleukin-2.
Caliendo G; Joyce D; Altmiller MC
Semin Oncol Nurs; 1993 Aug; 9(3 Suppl 1):25-31. PubMed ID: 8210791
[No Abstract] [Full Text] [Related]
4. [Chemistry and tolerance of water-soluble iodinated contrast media].
Caille JM
Riv Neurobiol; 1984; 30(2-3):89-95. PubMed ID: 6544511
[No Abstract] [Full Text] [Related]
5. [Fundamentals on iodinated contrast media and adverse reactions].
Feltrin GP; Zandonà M; Borile V; Rettore C; Miotto D
Radiol Med; 2004 Apr; 107(4 Suppl 1):8-31. PubMed ID: 15323318
[No Abstract] [Full Text] [Related]
6. [Adverse reactions to contrast media].
Leyva Carmona MI; Orea Solano M
Rev Alerg Mex; 1997; 44(5):128-34. PubMed ID: 9432274
[No Abstract] [Full Text] [Related]
7. [Incidents with contrast media].
Canigiani G
Wien Med Wochenschr; 1970 Aug; 120(33):563-70. PubMed ID: 4397419
[No Abstract] [Full Text] [Related]
8. [Adverse effects of hypotensive agents].
Horák O
Cas Lek Cesk; 1970; 109(41):969-72. PubMed ID: 5473530
[No Abstract] [Full Text] [Related]
9. Anaphylactoid reactions to iodinated contrast media.
Hildreth EA
Hosp Pract (Off Ed); 1987 May; 22(5A):77-85, 89-90, 95. PubMed ID: 3108279
[No Abstract] [Full Text] [Related]
10. [Side effects of gold salts].
Renier JC; Boasson M
Therapie; 1976; 31(3):365-76. PubMed ID: 136766
[No Abstract] [Full Text] [Related]
11. Reactions to iodinated contrast.
Shymko MJ
Radiol Technol; 2001; 72(4):381-2. PubMed ID: 11269824
[No Abstract] [Full Text] [Related]
12. [Nephrotoxicity of iodinated contrast products].
Christin F; Pottecher T
Ann Fr Anesth Reanim; 2000 Aug; 19(7):fi128-30. PubMed ID: 10976363
[No Abstract] [Full Text] [Related]
13. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
[No Abstract] [Full Text] [Related]
14. [Guideline 'Precautionary measures for contrast media containing iodine'].
van Dijk Azn R; Wetzels JF; ten Dam MA; Aarts NJ; Schimmelpenninck-Scheiffers ML; Freericks MP; Said SA; Geenen RW; Stuurman A; van Everdingen JJ
Ned Tijdschr Geneeskd; 2008 Mar; 152(13):742-6. PubMed ID: 18461890
[TBL] [Abstract][Full Text] [Related]
15. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].
Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021
[No Abstract] [Full Text] [Related]
16. [Unwanted side effects of bêta-blockers (author's transl)].
Hugues FC; Penso D; Marche J
Therapie; 1980; 35(2):155-71. PubMed ID: 6106306
[No Abstract] [Full Text] [Related]
17. [Problems and risks in the intravenous administration of iodinated contrast media].
Sehr A; Strejcek J
Cesk Radiol; 1987 Dec; 41(6):354-61. PubMed ID: 3442865
[No Abstract] [Full Text] [Related]
18. [Acute digitalis poisoning (70 cases)].
Gaultier M; Fournier E; Efthymiou ML; Frejaville JP; Jouannot P; Dentan M
Bull Mem Soc Med Hop Paris; 1968 Feb 9-16; 119(3):247-74. PubMed ID: 5703991
[No Abstract] [Full Text] [Related]
19. A critical review of the literature on carbon disulfide toxicity.
Beauchamp RO; Bus JS; Popp JA; Boreiko CJ; Goldberg L
Crit Rev Toxicol; 1983; 11(3):169-278. PubMed ID: 6349939
[No Abstract] [Full Text] [Related]
20. [Managing unique adverse effects of molecular targeted drugs].
Kobayashi T
Nihon Rinsho; 2012 Nov; 70 Suppl 8():671-7. PubMed ID: 23513920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
